# ent amgen · name Amgen · kind company · hub earnings · sub - · tier T1 · v K · symbol AMGN
# qa 14/14 (hub 99.4%): its own settled markets where our count matched the result
# next 2027-02-02 k:KXEARNINGSMENTIONAMGN-27FEB02 (15 words)
# last text 2026-11-03 earnings_call
# url https://parrot.markets/earnings/AMGN · as_of 2026-11-11T21:14:30Z
# 14 words with settled history; top 10 by n · tn/th: last 8 earnings call transcripts 2025-02-04..2026-11-03 · derived data CC BY 4.0 (credit parrot.markets) · not advice (parrot.markets/disclosure)
w	key	n	y	rate	l10	tn	th
Dazodalibep	dazodalibep	1	1	1	Y	8	3
Imfinzi / Durvalumab	durvalumab|imfinzi	1	1	1	Y	8	2
Eosinophilic	eosinophilic	1	1	1	Y	8	6
ESMO	esmo	1	1	1	Y	8	2
GLP-1 / GLP	glp|glp 1	1	1	1	Y	8	6
Medicare	medicare	1	1	1	Y	8	2
Acquisition	acquisition	1	0	0	n	8	5
Artificial Intelligence (3+ times)	artificial intelligence#3	1	0	0	n	8	1
Buyback / Buy Back	buy back|buyback	1	0	0	n	8	0
Litigation	litigation	1	0	0	n	8	1